The Oxford Handbook of Global Drug History

This book PDF is perfect for those who love History genre, written by Paul Gootenberg and published by Oxford University Press which was released on 02 May 2024 with total hardcover pages 721. You could read this book directly on your devices with pdf, epub and kindle format, check detail and related The Oxford Handbook of Global Drug History books below.

The Oxford Handbook of Global Drug History
Author : Paul Gootenberg
File Size : 51,8 Mb
Publisher : Oxford University Press
Language : English
Release Date : 02 May 2024
ISBN : 9780190842642
Pages : 721 pages
Get Book

The Oxford Handbook of Global Drug History by Paul Gootenberg Book PDF Summary

"This essay reveals how a global "New Drug History" has evolved over the past three decades, along with its latest thematic trends and possible next directions. Scholars have long studied drugs, but only in the 1990s did serious archival and global study of what are now illicit drugs emerge, largely from the influence of the anthropology of drugs on history. A series of key interdisciplinary influences are now in play beyond anthropology, among them, commodity and consumption studies, sociology, medical history, cultural studies, and transnational history. Scholars connect drugs and their changing political or cultural status to larger contexts and epochal events such as wars, empires, capitalism, modernization, or globalizing processes. As the field expands in scope, it may shift deeper into non-western perspectives, a fluid historical definition of drugs; environmental concerns; and research on cannabis and opiates sparked by their current transformations or crises"--

The Oxford Handbook of Global Drug History

"This essay reveals how a global "New Drug History" has evolved over the past three decades, along with its latest thematic trends and possible next directions. Scholars have long studied drugs, but only in the 1990s did serious archival and global study of what are now illicit drugs emerge, largely

Get Book
The Oxford Handbook of Global Drug History

"This essay reveals how a global "New Drug History" has evolved over the past three decades, along with its latest thematic trends and possible next directions. Scholars have long studied drugs, but only in the 1990s did serious archival and global study of what are now illicit drugs emerge, largely

Get Book
The Oxford Handbook of Oral History

'The Oxford Handbook of Oral History' brings together 40 authors on five continents to address the evolution of oral history, the impact of digital technology, the most recent methodological and archival issues and the application of oral history to both scholarly research and public presentations.

Get Book
The Oxford Handbook of Global Modernisms

The Oxford Handbook of Global Modernisms expands the scope of modernism beyond its traditional focus on English and Irish literature to explore the contributions of artists from countries like the US, Cuba, Spain, the Balkans, China, Japan, India, Vietnam, and Nigeria.

Get Book
The Oxford Handbook of Organized Crime

This handbook explores organized crime, which it divides into two main concepts and types: the first is a set of stable organizations illegal per se or whose members systematically engage in crime, and the second is a set of serious criminal activities that are typically carried out for monetary gain.

Get Book
The Oxford Handbook of the History of Medicine

In three sections, the Oxford Handbook of the History of Medicine celebrates the richness and variety of medical history around the world. It explore medical developments and trends in writing history according to period, place, and theme.

Get Book
The Oxford Handbook of the History of Physics

Presents a history of physics, examining the theories and experimental practices of the science.

Get Book
The Oxford Handbook of the Economics of the Biopharmaceutical Industry

The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with

Get Book